Cost and accessibility of empiric food elimination diets for treatment of eosinophilic oesophagitis

被引:9
作者
Sheedy, Katherine [1 ,2 ]
Patel, Nishaat [1 ]
Porter, Judi [3 ]
Silva, Hannah [1 ,4 ]
机构
[1] Eastern Hlth, Dept Nutr & Dietet, Box Hill, Vic, Australia
[2] Austin Hlth, Dept Nutr & Dietet, Heidelberg, Vic, Australia
[3] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr IPAN, Geelong, Vic, Australia
[4] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia
关键词
allergy; chronic disease management; clinical nutrition and dietetics; dietary intake; eosinophilic oesophagitis; food prices; GLUTEN-FREE DIET; MANAGEMENT; DIAGNOSIS; PRODUCTS; THERAPY;
D O I
10.1111/1747-0080.12717
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Aim This study aimed to investigate and compare the cost, affordability, and accessibility of three elimination diet approaches for the treatment of patients with eosinophilic esophagitis: the two-, four- and six-food elimination diets and with comparison to a standard diet. Methods An evidence-based modelling process was undertaken for costing and accessibility, including the development of three hypothetical reference families; four food baskets were modified from an established benchmark for each diet. Baskets were costed across eastern Melbourne, Australia. Affordability was modelled using two incomes: the equivalised disposable household income and welfare payments for reference families. Affordability was defined as 25% of a median weekly household income. Results All elimination diets were significantly more expensive than a standard diet and may be unaffordable for those receiving welfare. Prices significantly increased as the number of food allergens eliminated increased. Most items for a two-food elimination diet were available at major supermarkets; however, items for nutritionally complete four- and six-food elimination diets required a visit to a second store. Conclusion A step-up approach, commencing with a two-food elimination diet, instead of starting with a six-food elimination diet, may alleviate affordability barriers for most family types, which may enhance compliance. Clinicians should consider family type, financial situation, as well as accessibility of allergen-free foods in the patient's residential area when deciding on the most appropriate dietary or therapeutic treatment approach for eosinophilic oesophagitis.
引用
收藏
页码:238 / 246
页数:9
相关论文
共 35 条
  • [1] Facilitators and barriers to adherence to gluten-free diet among adults with celiac disease: a systematic review
    Abu-Janb, N.
    Jaana, M.
    [J]. JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2020, 33 (06) : 786 - 810
  • [2] Australian Bureau of Statistics, 2019, Household income and wealth, Australia
  • [3] Australian Bureau of Statistics, 2016, CENS POP HOUS GEN CO
  • [4] Australian Bureau of Statistics (ABS), 2018, National health survey first results, Australia 2017-18
  • [5] Australian Government, 2020, GUID AUSTR GOV PAYM
  • [6] Tutorial: Nutrition Therapy in Eosinophilic Esophagitis-Outcomes and Deficiencies
    Bashaw, Hillary
    Schwartz, Sally
    Kagalwalla, Amir F.
    Wechsler, Joshua B.
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2020, 44 (04) : 600 - 609
  • [7] It's time to determine the cost of a healthy diet in Australia
    Burns, Cate
    Friel, Sharon
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2007, 31 (04) : 363 - 365
  • [8] Celiac Disease Foundation, POL WORLD
  • [9] The development of the gluten free healthy food basket in Cyprus. Is it affordable among low-income adults diagnosed with celiac disease?
    Chrysostomou, S.
    Andreou, S. N.
    Andreou, Ch
    [J]. JOURNAL OF PUBLIC HEALTH, 2020, 42 (02) : 270 - 276
  • [10] Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis
    Cotton, Cary C.
    Erim, Daniel
    Eluri, Swathi
    Palmer, Sarah H.
    Green, Daniel J.
    Wolf, W. Asher
    Runge, Thomas M.
    Wheeler, Stephanie
    Shaheen, Nicholas J.
    Dellon, Evan S.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (06) : 841 - +